Russia's veterinary drug market, per RNC Pharma for January-August 2026, grew in value by 21.6% to ₽41.7 billion, and the National Veterinary Association forecasts it at ₽178.6 billion by 2030. Demand splits in two: 65% goes to the livestock sector, especially poultry, 35% to pets; by drug class, chemico-pharmaceutical (antibiotics, antiparasitics, anti-inflammatories) account for about 73%, vaccines and serums for 27% (RNC Pharma, Zooinform).
Imports are giving way to domestic production: in January-August 2026 the share of Russian veterinary drugs reached 57.9% in monetary terms and 75.5% in physical terms, sales of domestic products rose 23.3% in value, and Russian output overtook imports for the first time, the review recalls, in 2025. The most striking example is vaccines: in January-July their production in the country rose 12.5% to 19.8 billion doses of vaccines and toxoids (GXP News).
Supplies did not stop, though. The US share in value terms fell to 23.7%, but sales rose 8.5% in rubles and 14.6% in physical terms, and the review notes that growth was driven mainly by e-commerce, while traditional retail grew only 0.5%. The Czech Republic doubled supplies over eight months: sales of its rabies vaccines rose fourfold, and of vaccines against canine distemper and parvoviral enteritis sixfold. Physical sales of Slovenian and German drugs rose 13.3% and 9.9%, revenue from German ones fell 1% on the contrary, Belarusian supplies added 69% in physical terms, and Indian retail sales rose 53% with a sixfold revenue growth.
Import dependence stayed where it is not visible on the shelf: over 75% of active pharmaceutical substances used to make finished forms are imported, and key partners of Russian producers are China and India. Exports are only taking shape: over 11 months of last year Agroexport recorded a 70% year-on-year growth in veterinary vaccine exports to $43 million, with the top 3 buyers of Russian vaccines being Kazakhstan, Belarus and Uganda; final data for 2025 and 2026, the review notes, have not been published (Russia's Pivot to Asia).
The regulatory part for importers and wholesalers is already in force: mandatory marking of veterinary drugs in "Chestny Znak" took effect on March 1, 2026, except for vaccines stored at -60 °C and below, and from September 1, 2026 the digital traceability requirements expanded. Market participants transmit to the system data on identification codes, including group and transport packaging, when putting products into circulation and withdrawing them, and in transactions involving a change of owner.
The picture for external suppliers follows simply from these data: the finished form competes with imports inside the country, the subject of imports shifts to substances, where dependence on China and India exceeds three quarters, and to niche positions such as vaccines against specific diseases, where growth runs not in percent but in multiples. In both cases one has to check not only price and deadlines but also that codes and packaging data reach the system on time: from September 2026 this is a condition of circulation, not a recommendation.